Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The global landscape of cancer cell therapy.
Tang J, Hubbard-Lucey VM, Pearce L, O'Donnell-Tormey J, Shalabi A. Tang J, et al. Nat Rev Drug Discov. 2018 Jul;17(7):465-466. doi: 10.1038/nrd.2018.74. Epub 2018 May 25. Nat Rev Drug Discov. 2018. PMID: 29795477 No abstract available.
Trends in the global immuno-oncology landscape.
Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM. Tang J, et al. Nat Rev Drug Discov. 2018 Nov;17(11):783-784. doi: 10.1038/nrd.2018.167. Epub 2018 Oct 19. Nat Rev Drug Discov. 2018. PMID: 30337722 No abstract available.
Immuno-oncology drug development goes global.
Xin Yu J, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Among authors: hubbard lucey vm. Nat Rev Drug Discov. 2019 Nov;18(12):899-900. doi: 10.1038/d41573-019-00167-9. Nat Rev Drug Discov. 2019. PMID: 31780841 No abstract available.
Trends in the global immuno-oncology landscape.
Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM. Tang J, et al. Nat Rev Drug Discov. 2018 Dec;17(12):922. doi: 10.1038/nrd.2018.202. Epub 2018 Oct 26. Nat Rev Drug Discov. 2018. PMID: 30361553
The global pipeline of cell therapies for cancer.
Xin Yu J, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Nat Rev Drug Discov. 2019 Oct;18(11):821-822. doi: 10.1038/d41573-019-00090-z. Nat Rev Drug Discov. 2019. PMID: 31673124 No abstract available.
Trends in clinical development for PD-1/PD-L1 inhibitors.
Xin Yu J, Hodge JP, Oliva C, Neftelinov ST, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Among authors: hubbard lucey vm. Nat Rev Drug Discov. 2020 Mar;19(3):163-164. doi: 10.1038/d41573-019-00182-w. Nat Rev Drug Discov. 2020. PMID: 32127660 No abstract available.
25 results